Seminars of the Faculty of Pharmacy

The SARS-CoV-2 pandemic reminded us of the importance of vaccines as an essential tool to combat the often severe if not lethal consequences of infection with the virus. This brought to the forefront the issue of safety and the role of regulatory authorities in the process of evaluating a vaccine, a fundamental requirement for the acceptability of a new therapeutic or preventive product to the public. In the two seminars, Dr. Marco Cavaleri, Head of health threats and vaccines strategy - EMA, will explain the principles behind vaccine safety evaluation and the role that the European regulatory body plays in the approval procedures, illustrating the example of vaccines for SARS-CoV-2 in the analysis of the possible risk from their use and their therapeutic benefits.